Israel Chemicals Ltd (ICL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 798,000 | 83,000 | 109,000 | 79,000 | 81,000 |
| Marketable Securities | 78,000 | 90,000 | 86,000 | 293,000 | 285,000 |
| Receivables | 1,310,000 | 1,157,000 | 1,253,000 | 930,000 | 968,000 |
| Inventories | 1,255,000 | 1,226,000 | 1,208,000 | 1,276,000 | 1,248,000 |
| Other current assets | 0 | 169,000 | 122,000 | 122,000 | 122,000 |
| TOTAL | $3,441,000 | $2,725,000 | $2,778,000 | $2,700,000 | $2,704,000 |
| Non-Current Assets | |||||
| PPE Net | 4,577,000 | 4,521,000 | 4,458,000 | 4,419,000 | 4,349,000 |
| Investments And Advances | 249,000 | 241,000 | 283,000 | 239,000 | 271,000 |
| Intangibles | 732,000 | 722,000 | 839,000 | 844,000 | 829,000 |
| Other Non-Current Assets | 571,000 | 505,000 | 498,000 | 510,000 | 480,000 |
| TOTAL | $6,129,000 | $5,989,000 | $6,078,000 | $6,012,000 | $5,929,000 |
| Total Assets | $9,570,000 | $8,714,000 | $8,856,000 | $8,712,000 | $8,633,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 642,000 | 822,000 | 801,000 | 782,000 | 590,000 |
| Accounts payable and accrued liabilities | 736,000 | 790,000 | 694,000 | 717,000 | 695,000 |
| Other current liabilities | 748,000 | 716,000 | 750,000 | 686,000 | 793,000 |
| TOTAL | $2,126,000 | $2,328,000 | $2,245,000 | $2,185,000 | $2,078,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,503,000 | 2,388,000 | 2,658,000 | 2,663,000 | 2,791,000 |
| Other Non-Current Liabilities | 813,000 | 846,000 | 813,000 | 830,000 | 785,000 |
| TOTAL | $3,569,000 | $3,456,000 | $3,744,000 | $3,793,000 | $3,874,000 |
| Total Liabilities | $5,695,000 | $5,784,000 | $5,989,000 | $5,978,000 | $5,952,000 |
| Shareholders' Equity | |||||
| Common Shares | 545,000 | 545,000 | 545,000 | 544,000 | 544,000 |
| Retained earnings | 3,590,000 | 2,691,000 | 2,602,000 | 2,547,000 | 2,526,000 |
| Other shareholders' equity | -222,000 | -262,000 | -278,000 | -315,000 | -373,000 |
| TOTAL | $3,875,000 | $2,930,000 | $2,867,000 | $2,734,000 | $2,681,000 |
| Total Liabilities And Equity | $9,570,000 | $8,714,000 | $8,856,000 | $8,712,000 | $8,633,000 |